Money-saving messages lose impact over time, while worry about dangerous pollution helps consumers show discipline
Higher prices for the first few procedures, followed by a volume discount, may help balance risks and rewards
Peer ranking might cut dangerous antibiotic overuse
The anti-infection procedure rises for a time, when workers are watched, and then falls off
Informed by personal experience, a researcher parses data to help those mulling mastectomy and gynecological surgeries
A study looks at how changes in FDA labeling affect pediatric utilization of drugs
Just putting one where the last cardiac arrest occurred isn’t optimal — more calculations to get to fewer steps
Researchers aim to help the agency, drug companies and patients better understand the complex authorization process
Being stigmatized by stereotype feeds anxiety and depletes self-control
The empirical study of happiness, a growth area at business schools, enters the classroom
Pharmaceutical companies are better able to identify promising new applications for existing drugs
The happiest people are moderately patient, not into extreme delayed gratification
The goal is continued development of new drugs and reduction of often shocking prices
A model outperformed simpler statistical approaches in predicting which patients would encounter trouble
Embedding psychological nudges in mail reminding people to get tested improves compliance
Younger-patient mortality rate nearly triples, 20 years of data indicate